|
No records
|
|
660 |
Ramani S., McKimm J., Forrest K., Hays R., Bishop J., Thampy H., Findyartini A., Nadarajah V.D., Kusurkar R., Wilson K., Filipe H., Kachur E. |
56186462600;26433565200;26635053400;7202509928;8406026800;55349958700;56543777300;14048599600;6603461994;56926010000;36657108400;6603938626; |
Co-creating scholarship through collaborative writing in health professions education: AMEE Guide No. 143 |
2021 |
Medical Teacher |
|
|
|
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120044813&doi=10.1080%2f0142159X.2021.1993162&partnerID=40&md5=3773bd230107ba738a15f75175eba901 |
Harvard Medical School, Boston, United States; Manchester Medical School, University of Manchester, Manchester, United Kingdom; Swansea University Medical School, United Kingdom; Bond University, Queensland, Australia; James Cook University College of Medicine and Dentistry, James Cook University, Townsville, Australia; Department of Medical Education, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; International Medical University, Kuala Lumpur, Malaysia; Amsterdam UMC, Research in Education, Faculty of Medicine, Vrije Universiteit, Amsterdam, Netherlands; Dalhousie University, Halifax, NS, Canada; Hospital Egas Moniz, West Lisbon Hospitals Center (NHS), University of Lisbon, Lisboa, Portugal; Medical Education Development, Global Consulting, New York, NY, United States |
Ramani, S., Harvard Medical School, Boston, United States, Manchester Medical School, University of Manchester, Manchester, United Kingdom; McKimm, J., Swansea University Medical School, United Kingdom; Forrest, K., Bond University, Queensland, Australia; Hays, R., James Cook University College of Medicine and Dentistry, James Cook University, Townsville, Australia; Bishop, J., Bond University, Queensland, Australia; Thampy, H., Manchester Medical School, University of Manchester, Manchester, United Kingdom; Findyartini, A., Department of Medical Education, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Nadarajah, V.D., International Medical University, Kuala Lumpur, Malaysia; Kusurkar, R., Amsterdam UMC, Research in Education, Faculty of Medicine, Vrije Universiteit, Amsterdam, Netherlands; Wilson, K., Dalhousie University, Halifax, NS, Canada; Filipe, H., Hospital Egas Moniz, West Lisbon Hospitals Center (NHS), University of Lisbon, Lisboa, Portugal; Kachur, E., Medical Education Development, Global Consulting, New York, NY, United States |
This AMEE guide provides a robust framework and practical strategies for health professions educators to enhance their writing skills and engage in successful scholarship within a collaborative writing team. Whether scholarly output involves peer-reviewed articles, book chapters, blogs and online posts, online educational resources, collaborative writing requires more than the usual core writing skills, it requires teamwork, leadership and followership, negotiation, and conflict resolution, mentoring and more. Whilst educators can attend workshops or courses to enhance their writing skills, there may be fewer opportunities to join a community of scholars and engage in successful collaborative writing. There is very little guidance on how to find, join, position oneself and contribute to a writing group. Once individuals join a group, further questions arise as to how to contribute, when and whom to ask for help, whether their contribution is significant, and how to move from the periphery to the centre of the group. The most important question of all is how to translate disparate ideas into a shared key message and articulate it clearly. In this guide, we describe the value of working within a collaborative writing group; reflect on principles that anchor the concept of writing as a team and guide team behaviours; suggest explicit strategies to overcome challenges and promote successful writing that contributes to and advances the field; and review challenges to starting, maintaining, and completing writing tasks. We approach writing through three lenses: that of the individual writer, the writing team, and the scholarly product, the ultimate goal being meaningful contributions to the field of Health Professions Education. © 2021 AMEE. |
collaborative/peer-to-peer; Continuing; leadership; mentoring; staff development |
|
Taylor and Francis Ltd. |
0142159X |
|
|
Article |
Q1 |
1355 |
2689 |
|
|
|
668 |
Soebandrio A., Kusumaningrum T., Yudhaputri F.A., Oktavianthi S., Safari D., Malik S.G., Myint K.S.A. |
8602893200;55533156000;56464244900;38361976900;23493586700;7402973374;7003758970; |
COVID-19 prevalence among healthcare workers in Jakarta and neighbouring areas in Indonesia during early 2020 pandemic |
2021 |
Annals of Medicine |
53 |
1 |
|
1896 |
1904 |
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119260631&doi=10.1080%2f07853890.2021.1975309&partnerID=40&md5=1449d652b75cc7277061a388d5491234 |
Eijkman Institute for Molecular Biology, Jakarta, Indonesia; Faculty of Medicine, University of Indonesia, Jakarta, Indonesia |
Soebandrio, A., Eijkman Institute for Molecular Biology, Jakarta, Indonesia, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Kusumaningrum, T., Eijkman Institute for Molecular Biology, Jakarta, Indonesia; Yudhaputri, F.A., Eijkman Institute for Molecular Biology, Jakarta, Indonesia; Oktavianthi, S., Eijkman Institute for Molecular Biology, Jakarta, Indonesia; Safari, D., Eijkman Institute for Molecular Biology, Jakarta, Indonesia; Malik, S.G., Eijkman Institute for Molecular Biology, Jakarta, Indonesia; Myint, K.S.A., Eijkman Institute for Molecular Biology, Jakarta, Indonesia |
Background: The COVID-19 disease has overwhelmed and disrupted healthcare services worldwide, particularly healthcare workers (HCW). HCW are essential workers performing any job in a healthcare setting who are potentially directly or indirectly exposed to infectious materials. Our retrospective cohort study aimed to determine the prevalence of COVID-19 infections among HCW in Jakarta and neighbouring areas during the first three months of the pandemic. Methods: Nasopharyngeal/oropharyngeal swab specimens from HCW working at private and public hospitals in Jakarta and neighbouring areas were screened for SARS-CoV-2 between March and May 2020. Data on demography, clinical symptoms, contact history, and personal protective equipment (PPE) use were collected using standardised forms. Results: Among 1201 specimens, 7.9% were confirmed positive for SARS-CoV-2 with the majority coming from medical doctors (48.4%) and nurses (44.2%). 64.2% of the positive cases reported to have contact with suspect/confirmed COVID-19 cases, including 32 (52.2%) with patient and 3 (6.6%) with co-worker. The symptomatic HCW had a significantly lower median Ct value as compared to their asymptomatic counterpart (p <.001). Tendency to have a higher prevalence of pneumonia was observed in the age group of 40–49 and ≥50 years old. Conclusion: Our findings highlighted the necessity to implement proper preventive and surveillance strategies for this high-risk population including adherence to strict PPE protocol and appropriate training.Key Message Healthcare workers (HCW), defined as those handling any job in a healthcare setting, are at the frontline of risk of infection as SARS-CoV-2 is easily transmitted through airborne droplets and direct contact with contaminated surfaces. The aim of our study is to attain a more comprehensive and accurate picture of the impact of COVID-19 on HCW during the earlier phase of the outbreak in Indonesia to develop effective strategies that protect the health and safety of this workforce. Our findings highlighted that COVID-19 infections in HCW were mostly acquired in healthcare settings, with significant consequences of pneumonia and hospitalisation occurring across all age groups. © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. |
COVID-19; healthcare workers; Indonesia; transmission |
abdominal pain; adult; Article; cohort analysis; contact examination; controlled study; coronavirus disease 2019; coughing; demography; diarrhea; dizziness; dyspnea; female; headache; health care personnel; health status; human; Indonesia; major clinical study; malaise; male; medical history; myalgia; nasopharyngeal swab; neurologist; oropharyngeal swab; pandemic; pharmacist; physiotherapist; prevalence; private hospital; prospective study; public hospital; retrospective study; reverse transcription polymerase chain reaction; rhinorrhea; shivering; sore throat; thorax radiography; vomiting; aged; epidemiology; health care personnel; middle aged; prevalence; Adult; Aged; COVID-19; Female; Health Personnel; Humans; Indonesia; Male; Middle Aged; Pandemics; Prevalence; Retrospective Studies; S |
Taylor and Francis Ltd. |
07853890 |
|
34783269 |
Article |
Q1 |
1150 |
3535 |
|
|
|
669 |
Syafira N., Graudins A., Yarema M., Wong A. |
57222178056;55790181600;8550407600;52265101200; |
Comparing development of liver injury using the two versus three bag acetylcysteine regimen despite early treatment in paracetamol overdose |
2021 |
Clinical Toxicology |
|
|
|
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119253032&doi=10.1080%2f15563650.2021.1998518&partnerID=40&md5=71ecde369075113c2b3f41b9bb20e452 |
Department of Medicine, School of Clinical Science at Monash Health, Monash UniversityVIC, Australia; Faculty of Medicine, Universitas Indonesia, Special Capital Region of Jakarta, Indonesia; Monash Toxicology Unit, Dandenong Hospital, Monash HealthVIC, Australia; Poison and Drug Information Service, Alberta Health Services, Calgary, Canada; Department of Emergency Medicine, University of Calgary, Calgary, Canada; Austin Toxicology Unit, Austin HealthVIC, Australia; Department of Critical Care, University of MelbourneVIC, Australia |
Syafira, N., Department of Medicine, School of Clinical Science at Monash Health, Monash UniversityVIC, Australia, Faculty of Medicine, Universitas Indonesia, Special Capital Region of Jakarta, Indonesia; Graudins, A., Department of Medicine, School of Clinical Science at Monash Health, Monash UniversityVIC, Australia, Monash Toxicology Unit, Dandenong Hospital, Monash HealthVIC, Australia; Yarema, M., Poison and Drug Information Service, Alberta Health Services, Calgary, Canada, Department of Emergency Medicine, University of Calgary, Calgary, Canada; Wong, A., Department of Medicine, School of Clinical Science at Monash Health, Monash UniversityVIC, Australia, Austin Toxicology Unit, Austin HealthVIC, Australia, Department of Critical Care, University of MelbourneVIC, Australia |
Introduction: Some studies have reported that early administration of acetylcysteine using a 3-bag regimen may not fully prevent development of liver injury in some patients. We compared the incidence of acute liver injury (ALI) in patients receiving acetylcysteine within eight hours of ingestion between the two-bag acetylcysteine regimen (200 mg/kg over four hours, 100 mg/kg over 16 h) and the three-bag regimen (150 mg/kg over 1 h, 50 mg/kg over 4 h, 100 mg/kg over 16 h). Method: This was a retrospective cohort study of the two-bag and three-bag acetylcysteine regimens from Monash Health, Victoria, Australia (2009–2020), compared to the three-bag acetylcysteine regimen data from the Canadian Acetaminophen Overdose Study (CAOS) database (1980–2005). The inclusion criteria included patients with an acute single ingestion of paracetamol; normal aminotransferases on presentation and acetylcysteine administered within eight hours post-overdose. The primary outcome was development of ALI (defined as: peak aminotransferase >150 IU/L). Results: At Monash Health, 191 patients were treated with the two-bag acetylcysteine regimen, and 180 patients with the three-bag regimen. The CAOS cohort provided 515 patients treated with the three-bag regimen. ALI developed in 1.6% (3/191) of the two-bag Monash Health group, 2.2% (4/180) of the three-bag Monash Health group (difference −0.6%, p 0.7), and 2.9% (15/515) of the three-bag CAOS group (difference compared to two-bag −1.3%, p 0.4). Hepatotoxicity (ALT >1000) developed in 0.5% (1/191) of patients treated with the two-bag regimen, 1.7% (3/180) in the Monash Health three-bag regimen and 1% (5/515) of the three-bag CAOS group. There were no statistically significant differences between groups. Conclusions: ALI and hepatotoxicity were observed in a small, comparable percentage of patients despite early acetylcysteine administration using the two-bag and three-bag regimens. Repeating blood tests at the end of acetylcysteine treatment will identify these patients and indicate those requiring continuation of acetylcysteine. © 2021 Informa UK Limited, trading as Taylor & Francis Group. |
Acetaminophen; acute liver injury; hepatotoxicity |
|
Taylor and Francis Ltd. |
15563650 |
|
|
Article |
Q2 |
840 |
5641 |
|
|
|
708 |
Fajar Marta K., Moegni F. |
57270493200;55450456100; |
Level of agreement and acceptance of the 20-Minute versus 60-Minute sanitary pad test as a method for measuring the severity of stress urinary incontinence: randomised crossover trial |
2021 |
Journal of Obstetrics and Gynaecology |
|
|
|
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115614159&doi=10.1080%2f01443615.2021.1951689&partnerID=40&md5=937e03ea21fd672e116e87581915560c |
Department of Obstetrics and Gynecology, Faculty of Medicine Udayana University/Sanglah Hospital, Denpasar, Indonesia; Reconstructive Urogynecology Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia/Dr.Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
Fajar Marta, K., Department of Obstetrics and Gynecology, Faculty of Medicine Udayana University/Sanglah Hospital, Denpasar, Indonesia; Moegni, F., Reconstructive Urogynecology Division, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia/Dr.Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
We aimed to measure the level of agreement and acceptance ratio of the 20-minute versus 60-minute sanitary pad test in female patients with stress urinary incontinence (SUI). This is one-sample cross-experimental design. SUI patients at the Urogynecology Outpatient Clinic at Cipto Mangunkusumo Hospital in Jakarta, Indonesia were consecutively enrolled as participants. We first administered the 20-minute test, followed by the 60-minute test, or vice versa, within 1 week. The participants did not know the type of test performed or asked during the interview. Random Number Generator software by stattrek.com was used to determine which test was performed first for each participant. Participants were interviewed using a questionnaire at the end of each test. The 20-minute sanitary pad test exhibited a good level of agreement with the 60-minute sanitary pad test (kappa R = 0.84). Forty-two respondents (84.0%) reported that they were “satisfied” with the 20-minute sanitary pad test and eight respondents (16.0%) reported that they were “very satisfied”. There was a good agreement between the 20-minute and 60-minute sanitary pad test for assessing the severity of SUI. The 20-minute sanitary pad test achieved a relatively higher level of participant satisfaction.Impact statementWhat is already known on this subject? Patients at the Urogynecology Outpatient Clinic at Cipto Mangunkusumo Hospital have a positive acceptance in the 20-minute and 60-minute sanitary pad test for assessing the severity of SUI. What do the results of this study add? From this result, the authors considered that this method can help in assessing the severity of SUI, especially in Indonesia. What are the implications of these findings for clinical practice and/or further research? As these findings, the authors think that they might be useful as a standard of assessed the severity of SUI. This method does not harmful and easy to apply for every patient with SUI. © 2021 Informa UK Limited, trading as Taylor & Francis Group. |
agreement; Pad test; satisfaction; stress urinary incontinence |
|
Taylor and Francis Ltd. |
01443615 |
|
|
Article |
Q3 |
390 |
12371 |
|
|
|
720 |
Hariyanto A.D., Permata T.B.M., Gondhowiardjo S.A. |
57253039400;57197808751;6508327402; |
Role of CD4+CD25+FOXP3+ TReg cells on tumor immunity |
2021 |
Immunological Medicine |
|
|
|
|
|
|
|
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85114605951&doi=10.1080%2f25785826.2021.1975228&partnerID=40&md5=dee345614c66584e8dcc9d94211b7f1f |
Faculty of Medicine, Department of Radiotherapy, Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia |
Hariyanto, A.D., Faculty of Medicine, Department of Radiotherapy, Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Permata, T.B.M., Faculty of Medicine, Department of Radiotherapy, Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Gondhowiardjo, S.A., Faculty of Medicine, Department of Radiotherapy, Universitas Indonesia/Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia |
Not all T cells are effector cells of the anti-tumor immune system. One of the subpopulations of CD4+ T cells that express CD25+ and the transcription factor FOXP3, known as Regulator T cells (TReg), plays an essential role in maintaining tolerance and immune homeostasis preventing autoimmune diseases, minimalize chronic inflammatory diseases by enlisting various immunoregulatory mechanisms. The balance between effector T cells (Teff) and regulator T cells is crucial in determining the outcome of an immune response. Regarding tumors, activation or expansion of TReg cells reduces anti-tumor immunity. TReg cells inhibit the activation of CD4+ and CD8+ T cells and suppress anti-tumor activity in the tumor microenvironment. In addition, TReg cells also promote tumor angiogenesis both directly and indirectly to ensure oxygen and nutrient transport to the tumor. There is accumulating evidence showing a positive result that removing or suppressing TReg cells increases anti-tumor immune response. However, depletion of TReg cells will cause autoimmunity. One strategy to improve or restore tumor immunity is targeted therapy on the dominant effector TReg cells in tumor tissue. Various molecules such as CTLA-4, CD4, CD25, GITR, PD-1, OX40, ICOS are in clinical trials to assess their role in attenuating TReg cells’ function. © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of the Japanese Society of Clinical Immunology. |
anti-tumor immunity; immunotherapy; regulatory T cells; TReg; TReg-targeting therapy |
|
Taylor and Francis Ltd. |
25785826 |
|
|
Review |
Q3 |
419 |
11666 |
|
|
|
777 |
Sanjay S., Leo S.W., Au Eong K.G., Adriono G.A., Fong K.C.S., Anand K., Kadarisman R.S., Granet D.B., Mahendradas P., Shetty R., Souza S.D., Iyer S.P. |
24315097100;7004356152;7003590870;57199540275;57224986711;57205395095;6508028541;6701767974;16481136500;23478872600;57224976208;55828761800; |
Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown |
2021 |
Ophthalmic Epidemiology |
|
|
|
|
|
|
2 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108832186&doi=10.1080%2f09286586.2021.1934037&partnerID=40&md5=ba28f0a2d64e8a2f774b4efdf3e9b346 |
Department of Uvea and Ocular Immunology, Narayana Nethralaya, Bengaluru, India; Dr Leo Adult Paediatric Eye Specialist Pte Ltd, Mount Elizabeth Medical Centre, Singapore; International Eye Cataract Retina Center, Mount Elizabeth Medical Center and Farrer Park Medical Center, Singapore; Department of Ophthalmology Visual Sciences, Khoo Teck Puat Hospital, Singapore; Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Mangunkusumo Hospital, Jakarta, Indonesia; OasisEye Specialists, Kuala Lumpur, Malaysia; Great Plains Health Callahan Cancer Center, University of Nebraska, North PlatteNE, United States; Aini Eye Clinic, Jakarta Hospital, Jakarta, Indonesia; Ratner Children’s Eye Center, Shiley Eye Institute, University of California, San Diego, United States; Department of Cornea and Refractive Services, Narayana Nethralaya, Bengaluru, India; Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States |
Sanjay, S., Department of Uvea and Ocular Immunology, Narayana Nethralaya, Bengaluru, India; Leo, S.W., Dr Leo Adult Paediatric Eye Specialist Pte Ltd, Mount Elizabeth Medical Centre, Singapore; Au Eong, K.G., International Eye Cataract Retina Center, Mount Elizabeth Medical Center and Farrer Park Medical Center, Singapore, Department of Ophthalmology Visual Sciences, Khoo Teck Puat Hospital, Singapore; Adriono, G.A., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia, Mangunkusumo Hospital, Jakarta, Indonesia; Fong, K.C.S., OasisEye Specialists, Kuala Lumpur, Malaysia; Anand, K., Great Plains Health Callahan Cancer Center, University of Nebraska, North PlatteNE, United States; Kadarisman, R.S., Aini Eye Clinic, Jakarta Hospital, Jakarta, Indonesia; Granet, D.B., Ratner Children’s Eye Center, Shiley Eye Institute, University of California, San Diego, United States; Mahendradas, P., Department of Uvea and Ocular Immunology, Narayana Nethralaya, Bengaluru, India; Shetty, R., Department of Cornea and Refractive Services, Narayana Nethralaya, Bengaluru, India; Souza, S.D., Department of Cornea and Refractive Services, Narayana Nethralaya, Bengaluru, India; Iyer, S.P., Department of Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States |
Aim: To assess the impact of practice patterns amongst global ophthalmologists during severe acute respiratory syndrome Coronavirus 2 (SARS Cov2) causing Corona virus disease (COVID-19) and understand the various modifications made to address emergency surgeries and practice needs. Methods: An online survey was sent to practicing ophthalmologists around the world through email, Whatsapp™ ListServ17.0™ (for pediatric ophthalmologists), WeChat™ (China) and ophthalmology associations (Indonesia, Philippines, Ireland). All queries were collected and categorized. Responses to the queries were given according to the recommendations by the Ophthalmology association. Practices ability to deal with the COVID were also classified according to country and type of access to PPE. Statistical analyses of the association between these data and queries, where appropriate were carried out. Results: One thousand nine hundred sixteen ophthalmologists were invited to participate in a survey between April 10th and April 30th, 2020 of which 1207 responded, which is a response rate of approximately 63%. The majority of respondents were from India, Indonesia, China, Singapore and the USA. Our study indicates a precipitous drop in surgical procedures with 46% (n = 538) ophthalmologists ceased to operate on their patients and almost 40% (n = 486) were doing less than 25% of their original number of surgeries. The intent to resume elective surgeries was a consideration in 41% (n = 495) after an evaluation of the situation and in consultation with professional bodies. More than 2/3 of the respondents (n = 703) made it a priority to use and mandate their patients to practice physical distancing, wearing masks, and hand dis-infection for protection to limit the spread of infection. Conclusion: This global survey provides a real-world assessment of diverse practices that were in various forms of “shut down mode” and circumstances with varying capabilities to deal with COVID. It is unprecedented that the collective wisdom for a curtailment of practice has had an enormous immediate and far reaching implications on the livelihoods of ophthalmologists, their staff, and their families. Nevertheless, ophthalmologists and their staff remain resilient and have adapted to these changes pragmatically. © 2021 Taylor & Francis Group, LLC. |
COVID19; ophthalmic surgery; outpatient consultations; PPE; telehealth |
|
Taylor and Francis Ltd. |
09286586 |
|
|
Article |
Q2 |
728 |
6800 |
|
|
|
794 |
Subali A.D., Wiyono L. |
57222071247;57207889054; |
Reverse Transcriptase Loop Mediated Isothermal Amplification (RT-LAMP) for COVID-19 diagnosis: a systematic review and meta-analysis |
2021 |
Pathogens and Global Health |
115 |
5 |
|
281 |
291 |
|
5 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107466709&doi=10.1080%2f20477724.2021.1933335&partnerID=40&md5=bc2cfc39928d141c8b322792377bdf60 |
Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia; Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
Subali, A.D., Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Wiyono, L., Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
COVID-19 pandemic has become a global public health priority. The rapid increase in infection numbers, along with a significant number of deaths, has made the virus a serious threat to human health. Rapid, reliable, and simple diagnostic methods are critical to controlling the disease. While Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is the current diagnostic gold standard, Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) appears to be a compelling alternative diagnostic test due to its greater simplicity, shorter time to obtain a result, and lower cost. This study examined RT-LAMP application for rapid identification of SARS-CoV-2 infection compared to the RT-PCR assay. A systematic review and meta-analysis was conducted over six scientific databases in accordance with PRISMA guidelines. Original studies published in English conducted on human clinical samples were included. Articles evaluating the sensitivity and specificity of RT-LAMP relative to RT-PCR were considered eligible. Quality assessment of bias and applicability was examined based on QUADAS-2. A total of 351 studies were found based on the keywords and search queries. Fourteen eligible case–control studies fit the mentioned criteria. Quality assessment using QUADAS-2 indicated alow risk of bias for all included studies. All case studies, containing 2,112 samples, had acumulative sensitivity of 95.5% (CI 97.5% = 90.8–97.9%) and cumulative specificity of 99.5% (CI 97.5% = 97.7–99.9%). The RT-LAMP assay could be areliable alternative COVID-19 diagnostic method due to its reduced cost and processing time compared to RT-PCR. RT-LAMP could potentially be utilized during critical high-throughput and high-demand situations. © 2021 Informa UK Limited, trading as Taylor & Francis Group. |
COVID-19; diagnostic test; RT-LAMP; RT-PCR; SARS-CoV-2 |
coronavirus RNA dependent RNA polymerase; coronavirus spike glycoprotein; envelope protein; nonstructural protein 3; nucleocapsid protein; RNA directed DNA polymerase; virus RNA; coronavirus disease 2019; diagnostic test accuracy study; human; limit of detection; meta analysis; nasopharyngeal swab; open reading frame; practice guideline; receiver operating characteristic; reverse transcription loop mediated isothermal amplification; reverse transcription polymerase chain reaction; Review; sensitivity and specificity; Severe acute respiratory syndrome coronavirus 2; systematic review; virus gene; genetics; molecular diagnosis; nucleic acid amplification; pandemic; COVID-19; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Pandemics; Reverse Transcriptase Polym |
Taylor and Francis Ltd. |
20477724 |
|
34086539 |
Review |
Q1 |
945 |
4761 |
|
|
